Good morning :)
Place Order
Add to Watchlist

Tarsons Products Ltd

TARSONS Share Price

199.841.00% (-2.01)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹1,073 cr, stock is ranked 1,443

Stock is 3.72x as volatile as Nifty

TARSONS Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹1,073 cr, stock is ranked 1,443

Stock is 3.72x as volatile as Nifty

TARSONS Performance & Key Metrics

TARSONS Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
52.851.70
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.375.730.59%

TARSONS Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 
100%
Analysts have suggested that investors can buy this stock

from 2 analysts

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

TARSONS Company Profile

Tarsons Products Limited is engaged in the designing, development, manufacturing of a range of labware products which helps scientific discovery and healthcare

Investor Presentation

View older View older 

Feb 6, 2026

PDF
View Older Presentations

TARSONS Similar Stocks (Peers)

Compare with peers Compare with peers 

TARSONS Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
56.53
56.53
1Y Return
2.85%
2.85%
Buy Reco %
77.78
77.78
PE Ratio
39.58
39.58
1Y Return
37.23%
37.23%
Buy Reco %
80.00
80.00
PE Ratio
1,780.59
1,780.59
1Y Return
47.27%
47.27%
Buy Reco %
0.00
0.00
PE Ratio
78.79
78.79
1Y Return
157.02%
157.02%
Buy Reco %
0.00
0.00
PE Ratio
39.12
39.12
1Y Return
15.25%
15.25%
Buy Reco %
0.00
0.00
Compare with Peers

TARSONS Sentiment Analysis

TARSONS Sentiment Analysis

New
Crisp summary & key insights to decode earnings calls instantly

TARSONS Stock Summary · February 2026

The company is strategically positioning itself to capitalize on the significant growth in India's plastic labware industry, driven by healthcare and biotechnology demands. While navigating operational challenges, including a complex working capital cycle and the need for optimized inventory management, it remains focused on enhancing its product portfolio and transitioning to a solutions provider for the biopharmaceutical sector. Recent currency depreciation has created favorable conditions for domestic products, allowing the company to leverage its competitive edge in both local and international markets. Despite facing intense competition and the need for effective pricing strategies, strong customer loyalty and ongoing engagement initiatives are expected to bolster revenue growth. The management's cautious approach to capital expenditure, coupled with optimism about future profitability, underscores a commitment to sustainable expansion amidst evolving market dynamics.

TARSONS Stock Growth Drivers
TARSONS Stock Growth Drivers
7
  • Strong Financial Performance

    Tarsons Products Limited has reported significant financial growth, with a standalone revenue of approximately INR

  • Capacity Expansion and Product Development

    The company is actively expanding its production capacity, particularly at its Panchla facility, to meet

TARSONS Stock Challenges
TARSONS Stock Challenges
7
  • Decline in Profitability

    The company has reported a decline in profitability, with adjusted profit after tax (PAT) for

  • Challenges in Domestic Government Procurement

    The domestic government procurement process has faced significant challenges due to the Government e-Marketplace (GeM),

TARSONS Forecast

TARSONS Forecasts

Price

Revenue

Earnings

TARSONS

TARSONS

Income

Balance Sheet

Cash Flow

TARSONS Income Statement

TARSONS Income Statement

Loading...

Financial YearFY 2024FY 2025TTM
Total Revenue307.87408.37435.62
Raw Materialssubtract79.27131.05294.95
Power & Fuel Costsubtract10.8813.18
Employee Costsubtract44.2765.38
Selling & Administrative Expensessubtract26.4426.49
Operating & Other expensessubtract35.6945.43
Depreciation/Amortizationsubtract40.4062.5087.49
Interest & Other Itemssubtract10.1519.5421.50
Taxes & Other Itemssubtract18.1315.0311.36
EPS8.015.603.82
DPS2.000.000.00
Payout ratio0.250.000.00

TARSONS Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2026FY 2026

Annual Report Pending

Investor Presentation

Feb 6PDF
Nov 12PDF
Aug 12PDF
FY 2025FY 2025

Annual report

PDF

Investor Presentation

May 28PDF
Feb 14PDF
Nov 7PDF
FY 2024FY 2024

Annual report

PDF

Investor Presentation

Aug 12PDF
FY 2023FY 2023

Annual report

PDF

Investor Presentation

May 28PDF
Feb 12PDF
Nov 6PDF
FY 2022FY 2022

Annual report

PDF
 

TARSONS Stock Peers

TARSONS Past Performance & Peer Comparison

TARSONS Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CareHealth Care Equipment & Supplies

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Tarsons Products Ltd36.081.70
Inventurus Knowledge Solutions Ltd56.5315.35
Poly Medicure Ltd39.584.840.26%
Fischer Medical Ventures Ltd1,780.597.850.12%

TARSONS Stock Price Comparison

Compare TARSONS with any stock or ETF
Compare TARSONS with any stock or ETF
TARSONS
Loading...

TARSONS Holdings

TARSONS Shareholdings

TARSONS Promoter Holdings Trend

TARSONS Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

TARSONS Institutional Holdings Trend

TARSONS Institutional Holdings Trend

Increased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has increased by 1.90%

Decreased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has decreased by 3.36%

Tickertape Separator

TARSONS Shareholding Pattern

TARSONS Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding47.30%0.00%0.00%2.47%50.23%

Mar 2025

Jun 2025

Sep 2025

Dec 2025

TARSONS Shareholding History

TARSONS Shareholding History

SepDec '24MarJunSepDec '258.04%7.51%9.52%9.14%5.82%2.47%

Mutual Funds Invested in TARSONS

Mutual Funds Invested in TARSONS

No mutual funds holding trends are available

Top 2 Mutual Funds holding Tarsons Products Ltd



Funds (Top 2)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
0.0003%0.02%-0.00%114/123 (-2)
0.0001%0.00%-0.00%952/1038 (+2)

Compare 3-month MF holding change on Screener

TARSONS Insider Trades & Bulk Stock Deals

TARSONS Insider Trades & Bulk Stock Deals

Loading...

smallcases containing TARSONS stock

smallcases containing TARSONS stock

Looks like this stock is not in any smallcase yet.

TARSONS Events

TARSONS Events

TARSONS Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

TARSONS Dividend Trend

No dividend trend available

TARSONS Upcoming Dividends

TARSONS Upcoming Dividends

No upcoming dividends are available

TARSONS Past Dividends

TARSONS Past Dividends

Cash Dividend

Ex DateEx DateSep 20, 2024

Final
Final | Div/Share: ₹2.00

Dividend/Share

2.00

Ex DateEx Date

Sep 20, 2024

TARSONS Stock News & Opinions

TARSONS Stock News & Opinions

Corporate
Board of Tarsons Products approves investment of EUR 3 million in Tarsons Life Science

The board of Tarsons Products at its meeting held on 06 February 2026 has approved equity infusion of further EUR 3 Million in its wholly-owned subsidiary, Tarsons Life Science, a company incorporated in Singapore for meeting its operational and financial expenses.Powered by Capital Market - Live

1 week agoCapital Market - Live
Corporate
Board of Tarsons Products approves change in directorate

The board of Tarsons Products at its meeting held on 06 February 2026 has approved the appointment of Vinesh Mohan Kriplani (DIN: 08212644) as an Additional Director (Category: Non-Executive Independent Director). The board also accepted the resignation of Girish Paman Vanvari (DIN:07376482) as an Independent Director of the Company. Powered by Capital Market - Live

1 week agoCapital Market - Live
Earnings
Tarsons Products consolidated net profit declines 4.18% in the December 2025 quarter

Net profit of Tarsons Products declined 4.18% to Rs 5.04 crore in the quarter ended December 2025 as against Rs 5.26 crore during the previous quarter ended December 2024. Sales rose 12.76% to Rs 107.89 crore in the quarter ended December 2025 as against Rs 95.68 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales107.8995.68 13 OPM %29.2130.97 - PBDT33.8925.46 33 PBT8.868.05 10 NP5.045.26 -4 Powered by Capital Market - Live

1 week agoCapital Market - Live
Corporate
Tarsons Products to conduct board meeting

Tarsons Products will hold a meeting of the Board of Directors of the Company on 6 February 2026.Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Earnings
Tarsons Products consolidated net profit declines 67.74% in the September 2025 quarter

Net profit of Tarsons Products declined 67.74% to Rs 3.32 crore in the quarter ended September 2025 as against Rs 10.29 crore during the previous quarter ended September 2024. Sales rose 3.10% to Rs 102.33 crore in the quarter ended September 2025 as against Rs 99.25 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales102.3399.25 3 OPM %26.8225.49 - PBDT28.0728.90 -3 PBT5.5914.87 -62 NP3.3210.29 -68 Powered by Capital Market - Live

3 months agoCapital Market - Live
Earnings
Tarsons Products standalone net profit declines 49.50% in the September 2025 quarter

Net profit of Tarsons Products declined 49.50% to Rs 6.53 crore in the quarter ended September 2025 as against Rs 12.93 crore during the previous quarter ended September 2024. Sales rose 0.49% to Rs 80.51 crore in the quarter ended September 2025 as against Rs 80.12 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales80.5180.12 0 OPM %32.4729.34 - PBDT29.0529.48 -1 PBT8.8817.52 -49 NP6.5312.93 -49 Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Tarsons Products announces board meeting date

Tarsons Products will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Tarsons Products AGM scheduled

Tarsons Products announced that the 42th Annual General Meeting(AGM) of the company will be held on 22 September 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live
Earnings
Tarsons Products consolidated net profit declines 55.72% in the June 2025 quarter

Net profit of Tarsons Products declined 55.72% to Rs 1.78 crore in the quarter ended June 2025 as against Rs 4.02 crore during the previous quarter ended June 2024. Sales rose 7.74% to Rs 91.36 crore in the quarter ended June 2025 as against Rs 84.80 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales91.3684.80 8 OPM %27.0422.11 - PBDT22.9717.35 32 PBT3.036.32 -52 NP1.784.02 -56 Powered by Capital Market - Live

6 months agoCapital Market - Live
Corporate
Tarsons Products to discuss results

Tarsons Products will hold a meeting of the Board of Directors of the Company on 12 August 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Tarsons Products Ltd (TARSONS) today?

    The share price of TARSONS as on 18th February 2026 is ₹199.84. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Tarsons Products Ltd (TARSONS) share?

    The past returns of Tarsons Products Ltd (TARSONS) share are
    • Past 1 week: -5.52%
    • Past 1 month: -4.47%
    • Past 3 months: -12.62%
    • Past 6 months: -40.66%
    • Past 1 year: -35.01%
    • Past 3 years: -67.60%
    • Past 5 years: -75.34%

  3. What are the peers or stocks similar to Tarsons Products Ltd (TARSONS)?
  4. What is the market cap of Tarsons Products Ltd (TARSONS) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Tarsons Products Ltd (TARSONS) is ₹1073.97 Cr as of 18th February 2026.

  5. What is the 52 week high and low of Tarsons Products Ltd (TARSONS) share?

    The 52-week high of Tarsons Products Ltd (TARSONS) is ₹458 and the 52-week low is ₹188.42.

  6. What is the PE and PB ratio of Tarsons Products Ltd (TARSONS) stock?

    The P/E (price-to-earnings) ratio of Tarsons Products Ltd (TARSONS) is 36.08. The P/B (price-to-book) ratio is 1.70.

  7. Which sector does Tarsons Products Ltd (TARSONS) belong to?

    Tarsons Products Ltd (TARSONS) belongs to the Health Care sector & Health Care Equipment & Supplies sub-sector.

  8. How to buy Tarsons Products Ltd (TARSONS) shares?

    You can directly buy Tarsons Products Ltd (TARSONS) shares on Tickertape. Simply sign up, connect your demat account and place your order.